Skip to main content

OncoBeta launches International Registry for Non-Melanoma Skin Cancer

An observational, multicentre, international, non-interventional programme to register patients diagnosed with non-melanoma skin cancer (NMSC), to…

Read more
Skin Cancer Patients Now Have Greater Access to Rhenium-188 in South Africa

South African non-melanoma skin cancer patients now have greater access in the area of Johannesburg to innovative non-invasive treatment Rhenium-SCT®

Lethabong, South Africa, 16 November 2021: Today OncoBeta® GmbH, a medical device company specialising in innovative epidermal radioisotope therapies…

Read more

First non-melanoma skin cancer patients treated with the Rhenium-SCT® in Austria

Vienna, Austria, 28 October 2021: OncoBeta® GmbH, a medical device company specialized in innovative epidermal radioisotope therapies for non-melanoma…

Read more

OncoBeta initiates international EPIC-Skin study with Rhenium-SCT® for the treatment of Skin Cancer

The multi-centre prospective study will evaluate the efficacy of the Rhenium-SCT® in non-melanoma skin cancer patients

Garching n. Munich, Germany–…

Read more

Australian Nuclear Science and Technology Organization (ANSTO), the new production partner of OncoBeta® GmbH in Australia

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

Read more

New Non-Invasive Keloid Treatment using Rhenium-188 now available in South Africa

Province of Gauteng South Africa is first to offer an innovative single session keloid treatment without need of surgery 

Read more

OncoBeta Announces Approval and ARTG Listing of Rhenium-SCT (Rhenium-188 paste) in Australia for the treatment of skin cancer lesions and skin tumors

Garching n. Munich, Germany, (December 18th, 2020) – OncoBeta® GmbH and their subsidiary OncoBeta Therapeutics Pty Ltd. Australia a Medical Device…

Read more

OncoBeta GmbH and Australian Nuclear Science and Technology Organisation sign Letter of Intent to establish manufacturing site in Australia

Innovative medical device Rhenium-SCT therapy for Non-Melanoma Skin Cancer to be produced in Australia

Read more

Group RPH and OncoBeta GmbH sign agreement for Sales Referral and Distribution of Rhenium-SCT® in Brazil.

Grupo RPH is now the Official Rhenium-SCT® Sales Representative and Distributor in Brazil for the treatment of Non-Melanoma Skin Cancer.

Read more

Personalized irradiation therapy for NMSC by rhenium-188 skin cancer therapy: a long-term retrospective study

Abstract Objectives This study aimed to provide long-term clinical data about an innovative epidermal radioisotope therapy called Rhenium-SCT® (Skin…

Read more